Projects per year
Fingerprint
Dive into the research topics where Sonia Vallet is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Biomarker- based therapeutic prevention
Vallet, S., Podar, K. & Wiesner, C.
Gesellschaft für Forschungsförderung NÖ
1/12/19 → 1/12/22
Project: Other
-
JunB in multiple myeloma
Podar, K., Vallet, S., Lind, J., Czernilofsky, F., Kollmann, K. & Hundsberger, H.
Land NÖ - WST3 (Abteilung Wirtschaft, Tourismus amp Technologie)
1/10/18 → 30/09/22
Project: Other
Research output
-
Bone marrow microenvironment- induced regulation of Bcl-2 family members in multiple myeloma (MM): Therapeutic implications
Aksoy, O., Lind, J., Sunder-Plaßmann, V., Vallet, S. & Podar, K., Jan 2023, In: Cytokine. 161, p. 156062 156062.Research output: Journal article (peer-reviewed) › Journal article
Open Access -
1255 Impact of immune checkpoint inhibitors on bone turnover in cancer patients: prospective clinical study and preclinical correlates
Gassner, T., Vallet, S., Chittilappilly, C., Pirich, T., Lind, J., Aksoy, O., Sunder-Plassmann, V., Hackner, K., Zwickl-Traxler, E., Errhalt, P., Pecherstorfer, M. & Podar, K., 2022, (Submitted) In: Journal for ImmunoTherapy of Cancer. p. A1300-A1300Research output: Journal article (peer-reviewed) › Conference contribution to journal
-
Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents-A Prospective Cohort Study of the AGMT Study-Group
Leisch, M., Pfeilstöcker, M., Stauder, R., Heibl, S., Sill, H., Girschikofsky, M., Stampfl-Mattersberger, M., Tinchon, C., Hartmann, B., Petzer, A., Schreder, M., Kiesl, D., Vallet, S., Egle, A., Melchardt, T., Piringer, G., Zebisch, A., Machherndl-Spandl, S., Wolf, D., Keil, F., & 3 others, 1 May 2022, In: Cancers. 14, 10, 2459.Research output: Journal article (peer-reviewed) › Journal article
Open Access -
On the continuous (R)evolution of antibody-based and CAR T cell therapies in multiple myeloma: an early 2022 glance into the future
Sunder-Plassmann, V., Aksoy, O., Lind, J., Pecherstorfer, M., Vallet, S. & Podar, K., 2022, In: Expert Opinion on Pharmacotherapy. 23, 12, p. 1425-1444 20 p.Research output: Journal article (peer-reviewed) › Review article
-
Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study
Dieckmann, K-P., Pokrivcak, T., Geczi, L., Niehaus, D., Dralle-Filiz, I., Matthies, C., Dienes, T., Zschäbitz, S., Paffenholz, P., Gschliesser, T., Pichler, R., Mego, M., Bader, P., Zengerling, F., Heinzelbecker, J., Krausewitz, P., Krege, S., Aurilio, G., Aksoy, C., Hentrich, M., & 17 others, Mar 2022, In: Therapeutic Advances in Medical Oncology. 14, p. 17588359221086813Research output: Journal article (peer-reviewed) › Journal article
Open Access